Related Experiment Videos
Interactions of adriamycin with a calcium binding site
R G Canada1, W Saway, E Thompson
1Department of Physiology and Biophysics, Howard University College of Medicine, Washington, D.C. 20059.
Biochemical and Biophysical Research Communications
|March 15, 1988
Summary
Terbium luminescence revealed how adriamycin interacts with a calcium binding protein in pituitary tumor cells. Adriamycin binding was quantified, suggesting its accessibility to the cell membrane
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Adriamycin is a chemotherapy drug that interacts with cellular components.
- Calcium binding proteins play crucial roles in cell membrane functions.
- GH3/B6 pituitary tumor cells provide a model for studying drug-protein interactions.
Purpose of the Study:
- To investigate the interaction between adriamycin and a specific calcium binding protein in GH3/B6 pituitary tumor cells.
- To quantify the binding affinity and kinetics of adriamycin to the target protein.
- To elucidate the accessibility of the calcium binding site to adriamycin.
Main Methods:
- Utilized Terbium (Tb3+) luminescence spectroscopy to monitor protein-drug interactions.
- Applied Stern-Volmer analysis to quantify binding parameters.
- Investigated adriamycin's effect on Tb3+-GH3/B6 complex luminescence intensity and lifetime.
Main Results:
- Adriamycin quenched the luminescence of the Tb3+-GH3/B6 complex.
- Stern-Volmer analysis indicated binding of both free and membrane-bound adriamycin.
- Calculated binding affinity (Ka = 3.7 x 10(5) M-1) and quenching rate constant (kq = 7.3 x 10(7) M-1 s-1).
Conclusions:
- The calcium binding site on the cell membrane is accessible to freely diffusing adriamycin.
- Adriamycin's interaction suggests its receptor site is located near the bound metal ion.
- This study provides insights into the mechanism of adriamycin's cellular interactions.